ARCHIVES

In Brief: Best Guess On NCI Director: Brown First Choice, Benacerraf Second; FDa On Saccharin

This article is from The Cancer Letter archive.

Vol. 03 No. 16 | April 22, 1977

Download PDF Visit The Full Archive

Related Articles

Phase II Study Shows Positive Results in Reducing Dry Mouth

October 25, 2013

Group Chairs Urge NCI to Limit Authority of Steering Committees That Determine Which Trials Get Funded

August 5, 2011

In Brief: Budget Resolution Calls For 1% Cut In NIH, Then Six Years At 3% Below Current Budget

July 7, 1995

White House Yet To Name NCAB, Cancer Panel Members

February 11, 2011

Tykerb Plus Herceptin Better Than Monotherapy, Study Says

December 25, 2009

Tamoxifen Offers Long-Term Benefits For Prevention

March 30, 2007